Mitsubishi Tanabe Pharma Corporation (MTPC), has proudly pursued medical breakthroughs for more than 300 years.
In that time, the company discovered several distinctive treatments — considered first-in-class at launch — for serious diseases including diabetes (DM) and multiple sclerosis (MS). While these successes represent a strong part of our identity, we continue to build on that legacy by seeking new solutions to the pressing needs of patients.
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life- threatening illnesses. Today, MTPC group companies are focused on driving scientific discovery in many areas, including amyotrophic lateral sclerosis (ALS) and Parkinson’s disease.
